$127.42
7.145.94%
Last update: Nov 4, 4:00 PM
Haemonetics Corp
HAENYSE
The average analyst price target for Haemonetics is $112.09, 12.0% below the current price. Of 11 analysts, 9 rate it Buy and 2 Hold. Targets range from $74 to $140. The latest change came on Oct 9, 2026, when Barrington Research raised its price target on Haemonetics from $118 to $140 and kept an Outperform rating.
Price Target Range — 12 Quarters
Analyst Consensus — 11 Analysts
Rating Trend — Last 9 Months
